ARNOLD S FREEDMAN, MD
Osteopathic Medicine at Binney St, Boston, MA
License number
Massachusetts 47330
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
2
44 Binney St, Boston, MA 02115
1065 Walnut St, Newton, MA 02461
1065 Walnut St, Newton, MA 02461
Phone
(617) 632-4894
(617) 582-7890 (Fax)
(617) 969-2934
(617) 582-7890 (Fax)
(617) 969-2934
Personal information
See more information about ARNOLD S FREEDMAN at radaris.comName
Address
Phone
18 Lilac St, Sharon, MA 02067
1065 Walnut St, Newton Highlands, MA 02461
18 Lilac St, Sharon, MA 02067
Sharon, MA
Newton, MA
Professional information
Dr. Arnold S Freedman, Framingham MA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
761 Worcester Rd, Framingham 01701
(508) 788-1700 (Phone)
(508) 788-1700 (Phone)
Certifications:
Internal Medicine, 1982, Medical Oncology, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
761 Worcester Rd, Framingham 01701
Brigham and Women's Hospital
75 Francis St, Boston 02115
Massachusetts General Hospital
55 Fruit St, Boston 02114
North Shore Medical Center - Salem Hospital
81 Highland Ave, Salem 01970
Brigham and Women's Hospital
75 Francis St, Boston 02115
Massachusetts General Hospital
55 Fruit St, Boston 02114
North Shore Medical Center - Salem Hospital
81 Highland Ave, Salem 01970
Education:
Medical School
University Of Massachusetts Medical School
Graduated: 1979
Memorial Hospital Worcester
Dana Farber Cancer Institute
University Of Massachusetts Medical School
Graduated: 1979
Memorial Hospital Worcester
Dana Farber Cancer Institute
Arnold S Freedman, Boston MA
Specialties:
Oncologist
Address:
44 Binney St, Boston, MA 02115
Education:
University of Massachusetts, Medical School - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Arnold Freedman, Boston MA
Specialties:
Internal Medicine, Medical Oncology, Hematology
Work:
Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215 Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
450 Brookline Ave, Boston, MA 02215 Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
Education:
University of Massachusetts (1979)
Polypeptides Comprising A B7 Extracellular Domain
US Patent:
6653444, Nov 25, 2003
Filed:
May 30, 1995
Appl. No.:
08/453386
Inventors:
Gordon J. Freeman - Brookline MA
Arnold S. Freedman - Newton MA
Lee M. Nadler - Newton MA
Arnold S. Freedman - Newton MA
Lee M. Nadler - Newton MA
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C07K 14705
US Classification:
530350, 4241841, 4241851, 4241921, 514 2, 514 8, 514885, 536 231, 536 234, 536 235
Abstract:
Isolated nucleic acid molecules encoding a B cell activation antigen, B7, are provided. In one embodiment, the nucleic acid molecules are DNA sequences. The DNA sequences of the invention can be integrated into various expression vectors, which in turn can direct the synthesis of the corresponding proteins or peptides in a variety of hosts, particularly eukaryotic cells, such as mammalian and insect cell culture. Also provided are host cells transformed to produce proteins or peptides encoded by the DNA molecules of the present invention and purified proteins and peptides which comprise at least a portion of the B cell activation antigen. The proteins and peptides comprise at least a portion of the mature form of the B7 activation antigen and preferably comprise a soluble form of the B7 protein.
Dna Encoding, B7, A New Member Of The Ig Superfamily With Unique Expression On Activated And Neoplastic B Cells
US Patent:
6071716, Jun 6, 2000
Filed:
Nov 15, 1993
Appl. No.:
8/153262
Inventors:
Gordon J. Freeman - Brookline MA
Arnold S. Freedman - Newton MA
Lee M. Nadler - Newton MA
Arnold S. Freedman - Newton MA
Lee M. Nadler - Newton MA
Assignee:
Dana-Farber Cancer Institute - Boston MA
International Classification:
C12N 1500
US Classification:
435 691
Abstract:
Isolated nucleic acid molecules encoding a B cell activation antigen, B7, are provided. In one embodiment, the nucleic acid molecules are DNA sequences. The DNA sequences of the invention can be integrated into various expression vectors, which in turn can direct the synthesis of the corresponding proteins or peptides in a variety of hosts, particularly eukaryotic cells, such as mammalian and insect cell culture. Also provided are host cells transformed to produce proteins or peptides encoded by the DNA molecules of the present invention and purified proteins and peptides which comprise at least a portion of the B cell activation antigen. The proteins and peptides comprise at least a portion of the mature form of the B7 activation antigen and preferably comprise a soluble form of the B7 protein.
Dna Encoding B7, A New Member Of The Ig Superfamily With Unique Expression On Activated And Neoplastic B Cells
US Patent:
2003017, Sep 11, 2003
Filed:
Apr 19, 2002
Appl. No.:
10/126088
Inventors:
Gordon Freeman - Brookline MA, US
Arnold Freedman - Newton MA, US
Lee Nadler - Newton MA, US
Arnold Freedman - Newton MA, US
Lee Nadler - Newton MA, US
Assignee:
The Dana-Farber Cancer Institute
International Classification:
C12P021/02, C12N005/06, C07K014/705, C07H021/04
US Classification:
435/069300, 435/320100, 435/325000, 530/350000, 536/023200
Abstract:
Isolated nucleic acid molecules encoding a B cell activation antigen, B7, are provided. In one embodiment, the nucleic acid molecules are DNA sequences. The DNA sequences of the invention can be integrated into various expression vectors, which in turn can direct the synthesis of the corresponding proteins or peptides in a variety of hosts, particularly eukaryotic cells, such as mammalian and insect cell culture. Also provided are host cells transformed to produce proteins or peptides encoded by the DNA molecules of the present invention and purified proteins and peptides which comprise at least a portion of the B cell activation antigen. The proteins and peptides comprise at least a portion of the mature form of the B7 activation antigen and preferably comprise a soluble form of the B7 protein.
Monoclonal Antibodies To Antigen On Activated Human B-Cells And Assay Therefor, Protein Antigenic Determinant Therefor And Method Of Making Same
US Patent:
4692405, Sep 8, 1987
Filed:
Mar 5, 1985
Appl. No.:
6/708176
Inventors:
Arnold Freedman - Newton MA
Lee Nadler - Newton MA
Stuart Schlossman - Newton Center MA
Lee Nadler - Newton MA
Stuart Schlossman - Newton Center MA
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
G01N 5300, G01N 3353, C12P 2100, C12N 500
US Classification:
435 7
Abstract:
A monoclonal antibody recognizing an antigenic determinant on activated human B-cells, the antigenic determinant being characteized in that it is a protein distinct from B-LAST-1 and BB-1, the antibody being substantially unreactive with unactivated human B-cells.